<DOC>
	<DOCNO>NCT00813696</DOCNO>
	<brief_summary>The purpose study evaluate impact addition cisplatin gemcitabine treatment patient inoperable advanced pancreatic cancer .</brief_summary>
	<brief_title>Gemcitabine Gemcitabine Cisplatin Treatment Advanced Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologic cytologic diagnosis pancreatic cancer inoperable stage II stage III IV disease ( UICC , 1997 ) Age 18 75 year Karnofsky Performance status &gt; 50 Signed inform consent Previous chemotherapy Cerebral metastasis Previous malignancy past 5 year exclude adequately treat basal spinocellular skin cancer insitu cervical cancer Leukocytes &lt; 4000 neutrophil &lt; 2000 platelet &lt; 100000 hemoglobin &lt; 10 g/dl Creatinine value &gt; upper normal limit GOT GPT &gt; 2.5 time upper normal limit bilirubin &gt; 1.5 time upper normal limit absence hepatic metastasis Congestive heart failure , severe cardiac arrhythmia coronary ischemic disease Other concurrent disease would , investigator 's opinion , contraindicate use study drug Inability provide inform consent Inability comply followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>chemotherapy</keyword>
	<keyword>advanced cancer</keyword>
	<keyword>inoperable</keyword>
	<keyword>Stage II , III , IV</keyword>
</DOC>